New incident report
Incident Report Number: 2007-5518
Registrant Reference Number: 206822
Registrant Name (Full Legal Name no abbreviations): S.C. Johnson and Son, Limited
Address: 1 Webster Street
City: Brantford
Prov / State: ON
Country: Canada
Postal Code: N3T 5R1
Human
Country: CANADA
Prov / State: MANITOBA
PMRA Registration No. 27194 PMRA Submission No. EPA Registration No.
Product Name: (discontinued) OFF! Botanicals Insect Repellant Lotion (Canada)
Yes
Unknown
Site: Personal use / Usage personnel
Data Subject
Sex: Female
Age: >19 <=64 yrs / >19 <=64 ans
System
>1 wk <=1 mo / > 1 sem < = 1 mois
Yes
No
Non-occupational
Application
None
Skin
<=15 min / <=15 min
>8 hrs <=24 hrs / > 8 h < = 24 h
Caller reports that after applying product to her limbs on June 13, she developed hives and swelling of these treated areas within 16 hours of application. Symptoms did not improve over the several days following product application. Caller saw an MD and was prescribed Oral prednisone 5 days later. She was on this medication for 7 days and sxs were still present so she was prescribed topical betamethasone which she is still on. Sxs have improved.Follow-up on 7/10/2007 revealed that her symptoms had completely cleared with treatments.
Moderate
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.The differential diagnosis for a skin condition of this nature would include multiple potential etiologies which, in addition to this product, include such factors as plant allergens, poison ivy, poison oak, food, infectious pathogens, heat exposure, insect bites, etc. Skin patch testing would be required before labeling this product as the causative agent.